http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004202653-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2003-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02f4a13a2c72636ce1cf75febff2891f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcb619e29d762fae742ca479229f7922
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00133856e075c594410fabf47f790cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b7c00988d6caa235f85d24e49b0e2f1
publicationDate 2004-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004202653-A1
titleOfInvention Peptide-based passive immunization therapy for treatment of atherosclerosis
abstract The present invention relates to passive immunization for treating or preventing atherosclerosis using an isolated human antibody directed towards at least one oxidized fragment of apolipoprotein B in the manufacture of a pharmaceutical composition for therapeutical or prophylactical treatment of atherosclerosis by means of passive immunization, as well as method for preparing such antibodies, and a method for treating a mammal, preferably a human using such an antibody to provide for passive immunization.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10858422-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3524620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009208503-A1
priorityDate 2002-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5494791-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5861276-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5972890-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6225070-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127918344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135782887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57006608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112

Total number of triples: 54.